Biohaven Pharmaceutical Holding Company Ltd. (BHVN)
USD 36.0
(-7.98%)
USD 36.0
(-7.98%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -331.72 Million | -297.68 Million | -145.84 Million | -75.95 Million | -377.33 Million | -197.14 Million |
| Net Income | -408.16 Million | -570.27 Million | -213.79 Million | -118.66 Million | -528.8 Million | -240.92 Million |
| Depreciation & Amortization | 3.36 Million | 1.38 Million | 1.39 Million | 72 Thousand | - | - |
| Deferred income taxes | -35.52 Million | - | -5.26 Million | - | - | - |
| Stock-based compensation | 28.78 Million | 193.55 Million | 65.63 Million | 29.5 Million | 54.97 Million | 16.92 Million |
| Change in working capital | 24.61 Million | -28.6 Million | 1.66 Million | 8.97 Million | 3.31 Million | 5.39 Million |
| Other non-cash items | 55.19 Million | 106.25 Million | 4.52 Million | 4.16 Million | 93.18 Million | 21.46 Million |
| Investing Cash Flow | 129.83 Million | -304.79 Million | 944 Thousand | -2.69 Million | -3.78 Million | -10.54 Million |
| Investments in PPE | -3.04 Million | -41.07 Million | -938 Thousand | -2.69 Million | -2.53 Million | -4.16 Million |
| Acquisitions | - | -35 Million | 1.88 Million | 267.51 Million | - | - |
| Investment purchases | -194.12 Million | -263.71 Million | -193.29 Million | -319.39 Million | - | -6.37 Million |
| Sales/Maturities of investments | 326.99 Million | - | 221.56 Million | 94.98 Million | - | - |
| Other Investing Activities | 132.87 Million | -4 Million | -28.27 Million | -43.1 Million | -1.25 Million | - |
| Financing Cash Flow | 211.9 Million | 767.59 Million | 138.44 Million | 152.24 Million | 434.59 Million | 340.46 Million |
| Debt repayment | - | -449.13 Million | - | -2.24 Million | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 247.12 Million | 283.8 Million | 138.05 Million | 92.24 Million | - | 43.95 Million |
| Other Financing Activities | -35.21 Million | 932.92 Million | 395 Thousand | 62.24 Million | 434.59 Million | 296.5 Million |
| Accounts receivables | - | - | -188.15 Million | -120.11 Million | - | - |
| Accounts payables | 4.87 Million | 5.92 Million | 1.02 Million | 222 Thousand | 3.31 Million | 5.39 Million |
| Inventory | - | - | -24.1 Million | -37.96 Million | - | - |
| Other working capital | 19.73 Million | -34.53 Million | 212.89 Million | 166.83 Million | -3.31 Million | -5.39 Million |
| Cash at beginning of period | 240.2 Million | 77.05 Million | 83.5 Million | 9.91 Million | 264.24 Million | 131.46 Million |
| Cash at end of period | 249.72 Million | 242.6 Million | 77.05 Million | 83.5 Million | 317.72 Million | 264.24 Million |
| Capital Expenditure | -3.04 Million | -41.07 Million | -938 Thousand | -2.69 Million | -2.53 Million | -4.16 Million |
| Effect of forex changes on cash | -497 Thousand | 429 Thousand | -189 Thousand | 439 Thousand | - | - |
| Net cash flow / Change in cash | 9.51 Million | 165.54 Million | -6.44 Million | 73.58 Million | 53.47 Million | 132.78 Million |
| Free Cash Flow | -334.77 Million | -338.76 Million | -146.77 Million | -78.65 Million | -379.86 Million | -201.3 Million |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -319.77 Million | -179.5 Million | -408.16 Million | -144.75 Million | -102.57 Million | -90.34 Million |
| Depreciation & Amortization | 977 Thousand | 941 Thousand | 3.36 Million | 948 Thousand | 1.53 Million | 1.83 Million |
| Deferred income taxes | - | - | -35.52 Million | -17.76 Million | - | - |
| Stock-based compensation | 12.23 Million | 34.87 Million | 28.78 Million | 15.87 Million | 4.45 Million | 4.69 Million |
| Change in working capital | -23.3 Million | 25.61 Million | 24.61 Million | -8.71 Million | 2.78 Million | 41.36 Million |
| Other non-cash items | 176.25 Million | 52.19 Million | 55.19 Million | 39.54 Million | -1.01 Million | -1.93 Million |
| Investing Cash Flow | -97.93 Million | 34.03 Million | 129.83 Million | -3.91 Million | 58.54 Million | 76.25 Million |
| Investments in PPE | -2.94 Million | -440 Thousand | -3.04 Million | -470 Thousand | -1.24 Million | -595 Thousand |
| Acquisitions | - | 391 Thousand | - | - | - | -76.84 Thousand |
| Investment purchases | -196.18 Million | -47.08 Million | -194.12 Million | -111.29 Million | -29.45 Million | -23.55 Million |
| Sales/Maturities of investments | 101.2 Million | 81.16 Million | 326.99 Million | 107.85 Million | 89.24 Million | 100.39 Million |
| Other Investing Activities | -94.98 Million | 391 Thousand | 132.87 Million | -3.44 Million | 59.79 Million | 76.84 Thousand |
| Financing Cash Flow | 321.12 Million | 3.42 Million | 211.9 Million | 210.05 Million | -39.65 Million | -20.33 Million |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 320.88 Million | 2.2 Million | 247.12 Million | 247.12 Million | - | - |
| Other Financing Activities | 1.03 Million | 1.22 Million | -35.21 Million | -37.06 Million | -39.65 Million | -20.33 Million |
| Accounts receivables | - | - | - | - | - | - |
| Accounts payables | -19.12 Million | 19.06 Million | 4.87 Million | 6.06 Million | -2.52 Million | -2.41 Million |
| Inventory | - | - | - | - | - | - |
| Other working capital | -23.3 Million | 25.61 Million | 19.73 Million | -14.77 Million | 5.3 Million | 43.78 Million |
| Cash at beginning of period | 184.5 Million | 249.72 Million | 240.2 Million | 123.61 Million | 201.95 Million | 190.59 Million |
| Cash at end of period | 239.3 Million | 184.5 Million | 249.72 Million | 249.72 Million | 125.99 Million | 201.95 Million |
| Capital Expenditure | -2.94 Million | -440 Thousand | -3.04 Million | -470 Thousand | -1.24 Million | -595 Thousand |
| Effect of forex changes on cash | -7000.00 | -6000.00 | -497 Thousand | -310 Thousand | -40 Thousand | -162 Thousand |
| Net cash flow / Change in cash | 54.79 Million | -65.21 Million | 9.51 Million | 126.1 Million | -75.96 Million | 11.36 Million |
| Free Cash Flow | -170.74 Million | -103.07 Million | -334.77 Million | -115.35 Million | -96.06 Million | -44.98 Million |
3109
0MJH
3908
RIGL
5401
FATBW